GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Ypsomed Holding AG (CHIX:YPSNz) » Definitions » Capex-to-Operating-Income

Ypsomed Holding AG (CHIX:YPSNZ) Capex-to-Operating-Income : 2.27 (As of Mar. 2024)


View and export this data going back to 2013. Start your Free Trial

What is Ypsomed Holding AG Capex-to-Operating-Income?

Capex-to-Operating-Income measures a company's investments in physical assets such as property, industrial buildings or equipment to its operating income.

Ypsomed Holding AG's Capital Expenditure for the six months ended in Mar. 2024 was CHF-105.37 Mil. Its Operating Income for the six months ended in Mar. 2024 was CHF46.33 Mil.

Hence, Ypsomed Holding AG's Capex-to-Operating-Income for the six months ended in Mar. 2024 was 2.27.


Ypsomed Holding AG Capex-to-Operating-Income Historical Data

The historical data trend for Ypsomed Holding AG's Capex-to-Operating-Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ypsomed Holding AG Capex-to-Operating-Income Chart

Ypsomed Holding AG Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Capex-to-Operating-Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only 12.26 13.66 4.46 2.79 2.27

Ypsomed Holding AG Semi-Annual Data
Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24
Capex-to-Operating-Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 3.26 4.29 2.09 2.26 2.27

Competitive Comparison of Ypsomed Holding AG's Capex-to-Operating-Income

For the Medical Instruments & Supplies subindustry, Ypsomed Holding AG's Capex-to-Operating-Income, along with its competitors' market caps and Capex-to-Operating-Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ypsomed Holding AG's Capex-to-Operating-Income Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Ypsomed Holding AG's Capex-to-Operating-Income distribution charts can be found below:

* The bar in red indicates where Ypsomed Holding AG's Capex-to-Operating-Income falls into.



Ypsomed Holding AG Capex-to-Operating-Income Calculation

Ypsomed Holding AG's Capex-to-Operating-Income for the fiscal year that ended in Mar. 2024 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (-195.312) / 86.219
=2.27

Ypsomed Holding AG's Capex-to-Operating-Income for the quarter that ended in Mar. 2024 is calculated as

Capex-to-Operating-Income=- Capital Expenditure / Operating Income
=- (-105.366) / 46.332
=2.27

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ypsomed Holding AG  (CHIX:YPSNz) Capex-to-Operating-Income Explanation

Capex-to-Operating-Income assesses how much emphasis a company is placing upon investing in capital-intensive projects. The ratio is generally a good gauge to quantify how much focus on growth a company has. Typically, smaller companies that are still growing and expanding will have a higher Capex to Operating Income Ratio, since such businesses are likely investing more in physical assets. Lower ratios could indicate that a company has reached maturity and it is no longer pursuing aggressive growth.


Ypsomed Holding AG Capex-to-Operating-Income Related Terms

Thank you for viewing the detailed overview of Ypsomed Holding AG's Capex-to-Operating-Income provided by GuruFocus.com. Please click on the following links to see related term pages.


Ypsomed Holding AG (CHIX:YPSNZ) Business Description

Traded in Other Exchanges
Address
Brunnmattstrasse 6, Burgdorf, CHE, 3401
Ypsomed Holding AG is a Swiss company that develops and manufactures injection and infusion systems that allow patients to self-administer medication. Specifically, the company focuses on ensuring the ease of diabetes and insulin injection. The company offers various products such as pen needles with a unique click-on function. The company operates under two reportable segments: diabetes care and delivery systems goods and services. Diabetes care and delivery systems goods and services compose 55% and 40% of the company's sales, respectively.

Ypsomed Holding AG (CHIX:YPSNZ) Headlines

No Headlines